Total Payments
$2,438
2024 Payments
$13.52
Companies
28
Transactions
164
Medicare Patients
4,335
Medicare Billing
$470,881
Payment Breakdown by Category
Food & Beverage$2,433 (99.8%)
Education$5.40 (0.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,433 | 163 | 99.8% |
| Education | $5.40 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $400.38 | 35 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $302.86 | 38 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $251.45 | 19 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $212.94 | 18 | $0 (2019) |
| Amgen Inc. | $209.33 | 7 | $0 (2023) |
| Amarin Pharma Inc. | $145.92 | 4 | $0 (2019) |
| Kowa Pharmaceuticals America, Inc. | $123.42 | 1 | $0 (2017) |
| GlaxoSmithKline, LLC. | $120.57 | 9 | $0 (2019) |
| IDORSIA PHARMACEUTICALS US INC | $100.46 | 1 | $0 (2023) |
| Valeritas, Inc. | $97.07 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $13.52 | 1 | AstraZeneca Pharmaceuticals LP ($13.52) |
| 2023 | $239.16 | 3 | Amgen Inc. ($124.30) |
| 2022 | $59.62 | 2 | ACADIA Pharmaceuticals Inc ($45.62) |
| 2021 | $28.86 | 1 | AbbVie Inc. ($28.86) |
| 2019 | $918.54 | 60 | Novo Nordisk Inc ($188.40) |
| 2018 | $602.37 | 55 | Novartis Pharmaceuticals Corporation ($161.12) |
| 2017 | $576.20 | 42 | Novo Nordisk Inc ($155.99) |
All Payment Transactions
164 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Rare Disease | ||||||
| 10/01/2023 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 08/22/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.30 | General |
| Category: Cardiology | ||||||
| 04/13/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $100.46 | General |
| Category: INSOMNIA | ||||||
| 11/17/2022 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $45.62 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 09/29/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Central Nervous System | ||||||
| 03/22/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.86 | General |
| Category: ANTI-INFECTIVE | ||||||
| 12/17/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/26/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.67 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/25/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.20 | General |
| Category: Diabetes | ||||||
| 11/25/2019 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $0.35 | General |
| Category: Diabetes | ||||||
| 11/21/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $1.93 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/20/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/15/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2019 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.60 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/04/2019 | Lilly USA, LLC | TRULICITY (Drug) | Food and Beverage | In-kind items and services | $11.10 | General |
| Category: Diabetes | ||||||
| 10/30/2019 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/25/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $12.14 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/22/2019 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: PSYCHIATRY | ||||||
| 10/04/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: CNS | ||||||
| 09/18/2019 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug) | Food and Beverage | Cash or cash equivalent | $17.64 | General |
| Category: AED | ||||||
| 09/12/2019 | PFIZER INC. | LYRICA (Drug), COLOGUARD | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 08/30/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardiovascular & Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,784 | 3,792 | $638,177 | $243,311 |
| 2022 | 8 | 1,227 | 1,540 | $626,683 | $91,167 |
| 2021 | 9 | 923 | 1,037 | $563,707 | $86,773 |
| 2020 | 4 | 401 | 428 | $472,150 | $49,631 |
Total Patients
4,335
Total Services
6,797
Medicare Billing
$470,881
Procedure Codes
36
All Medicare Procedures & Services
36 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 412 | 1,558 | $178,554 | $83,435 | 46.7% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 315 | 848 | $108,469 | $45,337 | 41.8% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 268 | 308 | $76,081 | $31,051 | 40.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 225 | 321 | $46,604 | $25,875 | 55.5% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Office | 2023 | 181 | 198 | $48,373 | $19,788 | 40.9% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 125 | 198 | $32,574 | $15,933 | 48.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 97 | 151 | $17,000 | $6,994 | 41.1% |
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 47 | 48 | $69,691 | $6,486 | 9.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Facility | 2023 | 56 | 103 | $12,185 | $3,988 | 32.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 47 | 47 | $46,956 | $3,675 | 7.8% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2023 | 11 | 12 | $1,691 | $747.72 | 44.2% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 245 | 268 | $371,821 | $38,468 | 10.3% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Office | 2022 | 430 | 648 | $65,634 | $21,243 | 32.4% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 311 | 381 | $43,173 | $12,273 | 28.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 75 | 76 | $71,805 | $7,272 | 10.1% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Facility | 2022 | 59 | 59 | $10,466 | $4,083 | 39.0% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 51 | 52 | $32,604 | $3,103 | 9.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 12 | $21,762 | $1,922 | 8.8% |
| 99304 | Initial nursing facility visit per day, typically 25 minutes | Office | 2022 | 20 | 20 | $3,914 | $1,393 | 35.6% |
| 99305 | Initial nursing facility visit per day, typically 35 minutes | Facility | 2022 | 12 | 12 | $2,277 | $981.22 | 43.1% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Office | 2022 | 12 | 12 | $3,226 | $427.51 | 13.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 238 | 270 | $356,888 | $38,563 | 10.8% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 419 | 497 | $43,510 | $26,308 | 60.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 90 | 93 | $83,658 | $8,674 | 10.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 19 | 19 | $32,924 | $3,312 | 10.1% |
About Dr. Sean Stiltner, DO
Dr. Sean Stiltner, DO is a Emergency Medicine healthcare provider based in Piketon, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1821156472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sean Stiltner, DO has received a total of $2,438 in payments from pharmaceutical and medical device companies, with $13.52 received in 2024. These payments were reported across 164 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($2,433).
As a Medicare-enrolled provider, Stiltner has provided services to 4,335 Medicare beneficiaries, totaling 6,797 services with total Medicare billing of $470,881. Data is available for 4 years (2020–2023), covering 36 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Family Medicine
- Location Piketon, OH
- Active Since 12/05/2006
- Last Updated 01/30/2024
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1821156472
Products in Payments
- ENTRESTO (Drug) $302.86
- FARXIGA (Drug) $195.27
- Victoza (Drug) $191.05
- Ozempic (Drug) $188.40
- LATUDA (Drug) $187.49
- Vascepa (Drug) $145.92
- Repatha (Biological) $138.37
- Livalo (Drug) $123.42
- QUVIVIQ (Drug) $100.46
- V-GO (Device) $97.07
- XIFAXAN (Drug) $95.81
- NUPLAZID (Drug) $60.02
- Aimovig (Biological) $56.34
- TRELEGY ELLIPTA (Drug) $41.67
- TRULICITY (Drug) $38.51
- ANORO (Drug) $34.20
- ABILIFY MAINTENA (Drug) $33.67
- BREO (Drug) $31.69
- BRILINTA (Drug) $30.42
- DALVANCE (Drug) $28.86
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.